Inflammation: Planning for a Source of Pharmacokinetic/Pharmacodynamic Variability in Translational Studies

被引:22
作者
Schmith, V. D. [1 ]
Foss, J. F. [2 ]
机构
[1] GlaxoSmithKline, Dept Clin Pharmacol Modeling & Simulat, Res Triangle Pk, NC 27709 USA
[2] Cleveland Clin, Dept Gen Anesthesiol, Cleveland, OH 44106 USA
关键词
DRUG-DISEASE INTERACTIONS; RHEUMATOID-ARTHRITIS; METABOLIZING-ENZYMES; PHARMACOKINETICS; TRANSPORTERS; PROPRANOLOL; PHARMACODYNAMICS; DISPOSITION; EXPRESSION; MEDIATORS;
D O I
10.1038/clpt.2009.258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The impact of inflammation on variability in the pharmacokinetics (PK) and pharmacodynamics (PD) of drugs should be considered in the design, analysis, and interpretation of clinical pharmacology studies. Data suggest that the metabolism and transport of drugs, as well as the expression of receptors, may change in the presence of inflammation. The clinical implications of these changes are not straightforward; they may vary depending on whether the inflammation is active or controlled and may change with time and successful treatment of the inflammation.
引用
收藏
页码:488 / 491
页数:4
相关论文
共 50 条
[31]   Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies [J].
Zamarripa, C. Austin ;
Vandrey, Ryan ;
Spindle, Tory R. .
CURRENT ADDICTION REPORTS, 2022, 9 (04) :608-621
[32]   Under-representation of older adults in pharmacokinetic and pharmacodynamic studies: a solvable problem? [J].
Mangoni, Arduino A. ;
Jansen, Paul A. F. ;
Jackson, Stephen H. D. .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (01) :35-39
[33]   Factors that Impact the Pharmacokinetic and Pharmacodynamic Effects of Cannabis: a Review of Human Laboratory Studies [J].
C. Austin Zamarripa ;
Ryan Vandrey ;
Tory R. Spindle .
Current Addiction Reports, 2022, 9 :608-621
[34]   Adrenaline auto injectors pharmacokinetic/pharmacodynamic studies and potential consequences for clinical practice [J].
Worm, Margitta ;
Fox, Adam T. ;
Wickman, Magnus ;
Ring, Johannes ;
Ebisawa, Motohiro ;
Pouessel, Guillaume ;
Smith, Pete .
CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (12)
[35]   Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation [J].
Pelligand, L. ;
King, J. N. ;
Toutain, P. L. ;
Elliott, J. ;
Lees, P. .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 (01) :19-32
[36]   A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam [J].
Bhagunde, Pratik ;
Zhang, Zufei ;
Racine, Fred ;
Carr, Donna ;
Wu, Jin ;
Young, Katherine ;
Rizk, Matthew L. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 89 :55-61
[37]   Studies of pharmacokinetic, pharmacodynamic properties and bioequivalence of recombinant insulin glargine injection in healthy man [J].
Cheng Shi-wu ;
Lu Jun-ming ;
Pang Chang-yum .
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (12)
[38]   Transdermal delivery of flurbiprofen: Permeation enhancement, design, pharmacokinetic, and pharmacodynamic studies in albino rats [J].
Charoo, NA ;
Anwer, A ;
Kohli, K ;
Pillai, KK ;
Rahman, Z .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (03) :343-351
[39]   Pharmacokinetic and pharmacodynamic studies of pregabalin suppositories based on pharmacological research [J].
Yajima, Ryo ;
Matsumoto, Kazuaki ;
Yokono, Kanako ;
Watabe, Yuki ;
Enoki, Yuki ;
Taguchi, Kazuaki ;
Ise, Yuya ;
Katayama, Shiro ;
Kizu, Junko .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (05) :746-752
[40]   Microdialysis: A Technique for Pharmacokinetic-Pharmacodynamic Studies of Oncological Drugs [J].
Wei, Y. H. ;
Xu, L. Z. ;
Liu, L. ;
Shen, Q. ;
Li, F. Z. .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (06) :631-640